Bicocca Open Archive

Logo unimib boa
CHINELLO, CLIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.324
EU - Europa 5.327
AS - Asia 2.181
SA - Sud America 70
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 10
Totale 16.938
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.150
IT - Italia 1.503
DE - Germania 895
CN - Cina 798
SG - Singapore 737
IE - Irlanda 728
SE - Svezia 608
RU - Federazione Russa 352
HK - Hong Kong 294
GB - Regno Unito 268
AT - Austria 246
UA - Ucraina 227
CA - Canada 167
FR - Francia 102
FI - Finlandia 98
VN - Vietnam 87
DK - Danimarca 84
ID - Indonesia 66
IN - India 62
BR - Brasile 56
NL - Olanda 52
BE - Belgio 44
TR - Turchia 27
PL - Polonia 23
ES - Italia 21
IR - Iran 18
CZ - Repubblica Ceca 17
JP - Giappone 17
KR - Corea 15
RO - Romania 14
CH - Svizzera 12
TW - Taiwan 12
AU - Australia 10
EU - Europa 10
IL - Israele 8
PH - Filippine 7
TH - Thailandia 6
BG - Bulgaria 5
UZ - Uzbekistan 5
CL - Cile 4
GR - Grecia 4
HR - Croazia 4
LT - Lituania 4
MA - Marocco 4
MY - Malesia 4
NO - Norvegia 4
ZA - Sudafrica 4
AR - Argentina 3
EC - Ecuador 3
LU - Lussemburgo 3
PK - Pakistan 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
EG - Egitto 2
MX - Messico 2
PA - Panama 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BD - Bangladesh 1
BO - Bolivia 1
BT - Bhutan 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
IM - Isola di Man 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
PR - Porto Rico 1
PT - Portogallo 1
SC - Seychelles 1
TG - Togo 1
VE - Venezuela 1
VG - Isole Vergini Britanniche 1
Totale 16.938
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.127
Fairfield 773
Chandler 722
Dublin 719
Singapore 633
Woodbridge 626
Milan 604
Frankfurt am Main 600
Wilmington 530
Houston 506
Ashburn 484
Dearborn 358
Seattle 312
Hong Kong 289
Santa Clara 278
New York 250
Cambridge 244
Jacksonville 233
Vienna 232
Princeton 175
Shanghai 170
Nanjing 135
Jakarta 66
Lawrence 63
Altamura 62
Beijing 62
Fremont 59
Nanchang 56
Helsinki 51
Dong Ket 48
Los Angeles 48
Guangzhou 47
Brussels 41
Lachine 40
Council Bluffs 39
San Diego 39
Montréal 38
Ottawa 38
Toronto 31
Shenyang 29
Lissone 27
London 26
Andover 25
Chicago 23
Hebei 23
Munich 22
Changsha 20
Florence 20
Tianjin 20
Zhengzhou 20
Caronno Pertusella 19
Falls Church 19
Kunming 19
Pune 19
Rome 19
Boardman 18
Jiaxing 18
Jinan 18
Cinisello Balsamo 17
Brescia 16
Madison 16
Ningbo 16
Norwalk 16
Pavia 15
Como 14
Edmonton 14
Brno 13
Genoa 13
Kiev 13
Ripalta Cremasca 13
Romola 12
Washington 12
Dallas 11
Hangzhou 11
Melzo 11
Bonndorf 10
Mountain View 10
Monza 9
Padova 9
Taizhou 9
Verona 9
Bergamo 8
Cagliari 8
Carate Brianza 8
Huizen 8
Napoli 8
Nuremberg 8
Terni 8
Coventry 7
Kilburn 7
Lille 7
Messina 7
Minamikasugaoka 7
Nürnberg 7
Sacramento 7
Vercelli 7
Amsterdam 6
Atlanta 6
Kelty 6
Kraków 6
Totale 12.657
Salva come PNG Salva come JPEG
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 431
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 373
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 362
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 347
Differential protein profiling of renal cell carcinoma urinary exosomes 327
Urinary exosomes and diabetic nephropathy: a proteomic approach 302
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 279
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 279
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 276
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 272
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 271
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 268
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 266
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 262
The proteomic landscape of renal tumors 253
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 250
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 242
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 241
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 239
The putative role of MALDI-MSI in the study of Membranous Nephropathy 238
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 236
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 235
Robust conclusions in mass spectrometry analysis 231
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 228
Mutual Information Optimization for Mass Spectra Data Alignment 228
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 223
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 221
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 217
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 216
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 215
Tumor size, stage and grade alterations of urinary peptidome in RCC 205
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 205
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 204
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 204
Proteome analysis in thyroid pathology 199
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 199
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 195
Analysis of correlation structures in renal cell carcinoma patient data 191
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 187
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 186
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 186
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 186
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 183
Imaging mass spectrometry: a new tool for kidney disease investigations 177
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 167
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 167
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 167
Intraluminal proteome and peptidome of human urinary extracellular vesicles 164
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 163
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 162
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 161
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 161
A molecular imaging approach to individuate tumour infiltrating lymphocytes 158
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 157
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 156
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 153
Detection of high molecular weight proteins by MALDI imaging mass spectrometry 152
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 152
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 146
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 143
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 139
AQP1 expression analysis in human diseases: Implications for proteomic characterization 136
Proteomics imaging and the kidney 136
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 131
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 131
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 130
Immunoreattività e carcinoma renale 129
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 129
Characterization of distinguishing regions for Renal Cell Carcinoma discrimination 126
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 126
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 122
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 121
Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry 116
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 107
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 99
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 98
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 97
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 95
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 92
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 92
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 88
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 88
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 88
Method for the in vitro diagnosis of thyroid diseases 88
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 87
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 86
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 82
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 81
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 81
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 80
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 76
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 75
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 75
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 74
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 73
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 73
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 72
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 71
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 69
A Blood Bank Standardized Production of Human Platelet Lysate for Mesenchymal Stromal Cell Expansion: Proteomic Characterization and Biological Effects 63
Totale 17.186
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020949 0 0 0 0 0 0 0 209 267 202 195 76
2020/20212.733 122 148 294 286 220 225 329 292 205 224 154 234
2021/20221.539 145 146 134 196 79 127 54 96 60 123 149 230
2022/20232.911 299 818 282 322 148 416 38 183 191 35 94 85
2023/20242.325 68 67 106 173 249 652 481 56 144 44 53 232
2024/20252.427 222 473 345 220 481 215 318 153 0 0 0 0
Totale 17.783